tiprankstipranks
Instil Bio, Inc. (TIL)
NASDAQ:TIL
US Market

Instil Bio (TIL) Income Statement

375 Followers

Instil Bio Income Statement

Last quarter (Q4 2025), Instil Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Instil Bio's net income was $-8.19M. See Instil Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -534.00K$ 0.00$ 0.00$ -5.99M$ 0.00
Operating Expenses
$ 52.37M$ 73.54M$ 159.17M$ 200.18M$ 155.56M
Depreciation and Amortization
$ 534.00K$ 3.61M$ 4.76M$ 5.99M$ 2.75M
EBITDA
$ -52.37M$ -62.53M$ -147.12M$ -217.38M$ -152.51M
Operating Income
$ -52.91M$ -73.54M$ -159.17M$ -206.17M$ -155.56M
Other Income/Expenses
$ -18.46M$ -594.00K$ 3.08M$ -19.08M$ -1.20M
Pretax Income
$ -71.37M$ -74.14M$ -156.09M$ -225.25M$ -156.75M
Net Income
$ -71.37M$ -74.14M$ -156.09M$ -223.18M$ -156.79M
Per Share Metrics
Basic EPS
$ -10.70$ -11.39$ -24.00$ -34.46$ -29.60
Diluted EPS
$ -10.70$ -11.39$ -24.00$ -34.46$ -29.60
Weighted Average Shares Outstanding
6.67M 6.51M 6.50M 6.48M 5.30M
Weighted Average Shares Outstanding (Diluted)
6.67M 6.51M 6.50M 6.48M 5.30M
Currency in USD

Instil Bio Earnings and Revenue History